Skip to content

Ultrasonic phased array intelligent simulation acupuncture manipulation system

Ultrasonic phased array intelligent simulation acupuncture manipulation system

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054561
Enrollment
Unknown
Registered
2021-12-19
Start date
2022-01-10
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequela of cerebral infarction leads to limb movement disorder

Interventions

Control group:conventional therapy
Experimental group1:Traditional Chinese medicine treatment
Experimental group2:Instrument intervention

Sponsors

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as sequelae of cerebral infarction resulting in limb movement disorder, the diagnostic criteria are drawn up with reference to the "Stroke Diagnosis and Efficacy Evaluation Criteria"; 2. Those who meet the above diagnostic criteria for cerebral infarction aged 35 to 70 years; 3. The course of the disease is more than 1 month (in the recovery period of cerebral infarction or the sequelae period), and the patient is conscious; 4. Patients with muscle strength below grade IV, without serious heart, liver, kidney complications and diabetes; 5. Be able to understand the procedures and methods of this trial, voluntarily and strictly abide by the clinical trial protocol to complete this trial, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclude patients with unstable vital signs of consciousness; 2. Patients with severe heart, brain, kidney and hematopoietic system diseases; 3. Pregnant or lactating female patients; 4. Those who have not given birth and those who plan to become pregnant within one year; 5. Patients with pacemakers; 6. Patients with malignant tumor and mental illness; 7. The following conditions occur during the trial: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass grafting, heart failure, cerebrovascular accident (including transient ischemic attack); and epilepsy, severe liver disease Renal insufficiency, mechanical intestinal obstruction, bradycardia, bronchial asthma and other diseases; 8. The investigator believes that there are any other circumstances that may cause the subjects to fail to complete the study or bring obvious risks to the subjects.

Design outcomes

Primary

MeasureTime frame
Barthel Index;Functional Independence Rating Score;Six-stage evaluation scale for post-cerebral infarction recovery (Brunstrom);

Countries

China

Contacts

Public ContactDuan Junli

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University

duanjunlixh@163.com+86 13651626960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026